Patients with hepatorenal syndrome and lower baseline mean arterial pressure derive significant survival benefit from treatment with terlipressin

被引:0
|
作者
Kwo, Paul Yien [1 ]
Pyrsopoulos, Nikolaos T. [2 ]
Thuluvath, Paul J. [3 ]
Janardhan, Sujit [4 ]
Jamil, Khurram [5 ]
机构
[1] Stanford Hlth Care, Redwood City, CA USA
[2] Rutgers New Jersey Sch Med, Newark, NJ USA
[3] Mercy Med Ctr, Lutherville Timonium, MD USA
[4] Rush Univ, Chicago, IL USA
[5] Mallinckrodt Pharmaceut, Bridgewater, NJ USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
SAT-076
引用
收藏
页码:S240 / S241
页数:2
相关论文
共 30 条
  • [1] IMPROVED MEAN ARTERIAL PRESSURE FROM BASELINE TO THE END OF TREATMENT WITH TERLIPRESSIN IS ASSOCIATED WITH HEPATORENAL SYNDROME REVERSAL: A POOLED ANALYSIS OF 3 PHASE III STUDIES
    Fricker, Zachary
    Sanchez, Antonio J. J.
    Mayo, Marlyn J.
    Jamil, Khurram
    Curry, Michael P.
    HEPATOLOGY, 2023, 78 : S232 - S234
  • [2] Changes in mean arterial pressure are inadequate to guide treatment with terlipressin and albumin in patients with hepatorenal syndrome - acute kidney injury
    Calvino, V.
    Barone, A.
    Tonon, M.
    Gambino, C. G.
    Incicco, S.
    Gagliardi, R.
    Zeni, N.
    Angeli, P.
    Piano, S. S.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S64 - S64
  • [3] Terlipressin Treatment Is Associated with Significantly Increased Survival in Patients with Hepatorenal Syndrome Type 1 (HRS-1) and Low Baseline Mean Arterial Pressure (MAP), Independent of HRS Reversal
    Pappas, Stephen Chris
    Wong, Florence
    Escalante, Shannon
    Teuber, Peter
    Jamil, Khurram
    HEPATOLOGY, 2018, 68 : 560A - 560A
  • [4] BASELINE ACLF GRADE AND TREATMENT RESPONSE TO TERLIPRESSIN IN PATIENTS WITH HEPATORENAL SYNDROME
    Subramanian, Ram
    Olson, Jody
    Zafar, Zunaira
    Jamil, Khurram
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 542 - 542
  • [5] Changes in mean arterial pressure are inadequate to guide treatment with terlipressin and albumin in patients with hepatorenal syndrome-acute kidney injury
    Calvino, Valeria
    Barone, Anna
    Tonon, Marta
    Gambino, Carmine
    Incicco, Simone
    Gagliardi, Roberta
    Zeni, Nicola
    Angeli, Paolo
    Piano, Salvatore
    JOURNAL OF HEPATOLOGY, 2024, 80 : S243 - S243
  • [6] The Effect of Terlipressin on Blood Pressure, Mean Arterial Pressure, and Heart Rate in Patients with Hepatorenal Syndrome: A Post Hoc Analysis of the CONFIRM Study
    O'Leary, Jacqueline G.
    Lim, Nicholas
    Wong, Mark
    Sass, David
    Janardhan, Sujit
    Leventhal, Thomas M.
    Jamil, Khurram
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1122 - S1122
  • [7] Mean arterial pressure drop is an independent risk factor of hepatorenal syndrome in patients with HBV-ACLF
    Zheng, Xingrong
    Lian, Yunwen
    Wang, Peipei
    Zheng, Lihua
    Wu, Hewei
    Lin, Jiaxin
    Chen, Xiyao
    Gao, Zhiliang
    Peng, Liang
    Xie, Chan
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (05) : 576 - 584
  • [8] MEAN ARTERIAL PRESSURE AS AN INDEPENDENT PREDICTOR OF RESPONSE TO THERAPY WITH OCTREOTIDE, MIDODRINE, AND ALBUMIN IN PATIENTS WITH CIRRHOSIS AND HEPATORENAL SYNDROME
    Brown, Patrick R.
    Lenhart, Adrienne
    Khan, Omar
    Alimirah, Maryam
    Abdulla, Hafsa
    Salgia, Reena
    Uduman, Junior
    GASTROENTEROLOGY, 2018, 154 (06) : S1182 - S1182
  • [9] EFFECT OF TERLIPRESSIN ON MEAN ARTERIAL PRESSURE (MAP) AND ITS RELATION TO SERUM CREATININE CONCENTRATION (SCR) IN TYPE 1 HEPATORENAL SYNDROME (HRS): ANALYSIS OF DATA FROM THE PIVOTAL PHASE 3 TRIAL
    Sanyal, Arun J.
    Boyer, Thomas D.
    Garcia-Tsao, Guadalupe
    Blei, Andres T.
    Teuber, Peter
    HEPATOLOGY, 2008, 48 (04) : 1071A - 1071A
  • [10] UNDERSTANDING THE RELATIONSHIP BETWEEN MEAN ARTERIAL PRESSURE AND TERLIPRESSIN IN HEPATORENAL SYNDROME-ACUTE KIDNEY INJURY REVERSAL: A POST HOC ANALYSIS OF THE CONFIRM, REVERSE, AND OT-0401 TRIALS
    Cullaro, Giuseppe
    Patidar, Kavish R.
    Debakey, Michael E.
    Allegretti, Andrew S.
    Jamil, Khurram
    HEPATOLOGY, 2023, 78 : S1370 - S1371